Skip to content
Cyclodextrin News

Cyclodextrin News

A forum for researchers, students and applicants in the field of cyclodextrin technology

  • Home
  • Pharma applications
  • Non-pharma applications
  • CD derivatives
  • Events
  • E-ducation

Tag: photodynamic therapy

January 29, 2026 Drug delivery / Pharma applications

Poly(β-cyclodextrin)-coated dysprosium-doped ZnS nanocarriers

This study provides a comprehensive analysis of the structures and properties of zinc sulfide (ZnS) and dysprosium-doped ZnS nanoparticles (NPs)

Continue reading

July 18, 2025 Drug delivery / Pharma applications

Hypoxia-responsive core-cross-linked supramolecular nanoprodrug based on dendritic drug-drug conjugates for synergetic anticancer therapy

A hypoxia-responsive dendritic drug-drug conjugates IR806-(Azo-CB)4 was prepared and combined with β-cyclodextrin-pendant poly(ethylene glycol)-block-poly(glutamic acid) block copolymer (PEG-PGlu-CD) to construct

Continue reading

April 23, 2025 Drug delivery / Pharma applications

β-Cyclodextrin Encapsulated Platinum(II)-Based Nanoparticles: Photodynamic Therapy and Inhibition of the NF-κB Signaling Pathway in Glioblastoma

This study explores cell death through photodynamic therapy (PDT) with β-cyclodextrin-encapsulated platinum(II)-based nanoparticles (Pt-NPs) and the effect on the NF-κB

Continue reading

September 16, 2024 Drug delivery / Pharma applications

Multifunctional Molecular Hybrids Photoreleasing Nitric Oxide: Advantages, Pitfalls, and Opportunities

The multifaceted role nitric oxide (NO) plays in human physiology and pathophysiology has opened new scenarios in biomedicine by exploiting

Continue reading

November 22, 2023 Drug delivery / Pharma applications

Cyclodextrins: prospective nanocarriers for the delivery of antibacterial agents, against bacteria  that are resistant  to antibiotics

A review with 303 references Several different kinds of cyclodextrin nanocarriers (β-CD, HP-β-CD, Meth-β-CD, cationic CD, sugar-grafted CD) are utilized

Continue reading

September 25, 2023 CD as API / Drug delivery / Pharma applications

Application of Cyclodextrin for Cancer Immunotherapy

Tumor immunotherapy, compared with other treatment strategies, has the notable advantage of a long-term therapeutic effect for preventing metastasis and

Continue reading

August 14, 2023 Drug delivery / Pharma applications

Recent Advances for Dynamic-Based Therapy of Atherosclerosis

Atherosclerosis (AS) is a chronic inflammatory disease, which may lead to high morbidity and mortality. Currently, the clinical treatment strategy

Continue reading

May 9, 2023 Drug delivery / Pharma applications

Three-in-one: exploration of co-encapsulation of cabazitaxel, bicalutamide and chlorin e6 in new mixed cyclodextrin-crosslinked polymers

The MSCA-IF Polar Star project funded by the EC aimed at the development of a novel administration route for multiple

Continue reading

May 5, 2023 Drug delivery / Pharma applications

A Cyclodextrin Polymer as Supramolecular Matrix for Scalable Green Photooxygenation of Hydrophobic Substrates in Homogeneous Phase

In the frame of the HypoCyclo project, cyclodextrin-based polymers (BCDPS) are aimed to be used as suitable shuttle for the

Continue reading

January 25, 2023 Drug delivery / Pharma applications

Small anticancer drug release by light

Aiming to engineer simple, neutral, strongly amphiphilic photoactive nanoparticles (NPs) to specifically target cancer cell lysosomes for drug transport and

Continue reading

Posts pagination

1 2 Next Posts»

Recent Posts

  • 4th International Aquatic Biotechnology Symposium
  • Cyclodextrin metal-organic framework engineered titanium surface: Targeted modulation of foam cell lipid homeostasis and inflammatory resolution
  • Reviewing Cyclodextrin-Grafted Polysaccharides as Sustainable Platforms for Biomedical and Environmental Applications
  • Complexation of Citalopram with β-Cyclodextrin, Mono-Subetadex and Subetadex – A Comparison of Analytical Techniques
  • Effect of cyclodextrins on cardiometabolic indices: a systematic review and meta-analysis of randomized controlled trials

Tags

alpha-CD atherosclerosis Cancer therapy Captisol Cholesterol Clinical trial conference Covid-19 cyclodextrin polymer Dexolve drug delivery drug delivery systems electrospinning FDA Food gamma-CD Gilead HPBCD hydrogel methyl BCD Nanoparticles Niemann Pick Disease RAMEB remdesivir review SBECD Special issue Sugammadex Synthesis

Follow Us

  • LinkedIn
  • X
  • Facebook

Categories

  • Agriculture (27)
  • Analysis (73)
  • CD as API (352)
  • CD derivatives (427)
  • Cosmetics and toilettry (52)
  • Diagnosis (13)
  • Drug delivery (806)
  • E-ducation (63)
  • Environmental (143)
  • Events (237)
  • Food (230)
  • Gene delivery (22)
  • Household products (5)
  • Household products (1)
  • In Hungarian (4)
  • Life sciences (44)
  • Non-pharma applications (411)
  • Other industrial use (111)
  • Pharma applications (1,205)
  • Supramolecular systems (44)
  • Uncategorized (163)

Top Posts

  • Reviewing Cyclodextrin-Grafted Polysaccharides as Sustainable Platforms for Biomedical and Environmental Applications
  • 4th International Aquatic Biotechnology Symposium
  • FDA: Inclusion complex of a GRAS guest and a GRAS host is also GRAS
  • Are cyclodextrins safe for intravitreal injections?
  • Cyclodextrin metal-organic framework engineered titanium surface: Targeted modulation of foam cell lipid homeostasis and inflammatory resolution
  • Complexation of Citalopram with β-Cyclodextrin, Mono-Subetadex and Subetadex - A Comparison of Analytical Techniques
  • Practical Considerations about the Cyclodextrin Solubilities – A Quickstart Guide for Newbies
  • Antibody conjugated cyclodextrin for tumor drug delivery
  • FDA Grants Approval to HPBCD-Enhanced Biologic: A 'Super-Originator' Formulation
  • Impact of Cholesterol Depletion by Methyl BCD on Dopamine Transmission Dynamics in Brain

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 4,476 other subscribers
Loading Comments...